Acute Healthcare (Research)Research
The Process: Oncology
Client Sector: Acute Healthcare
Compare and contrast Intravenous and Subcutaneous (SC) treatment in patients with HER2-positive breast cancer.
On average, the total healthcare provider (HCP) time saved per SC treatment cycle relative to IV treatment cycle was 59.21 minutes. Time savings in favour of SC resulted from quicker drug reconstitution, no IV catheter installation and removal, and less HCP monitoring. Over a full treatment course of 17 cycles, average HCP time saved accumulates to 16.78 hours. Loss of productivity for patients receiving IV (2.15 days) was greater than that of SC (0.60 days) for a full treatment course.